Research advances in radiation-induced heart disease
Xu Liming,Chen Xi,Yuan Yajing,Zhao Lujun
Department of Radiation Oncology (Xu Liming,Chen Xi,and Zhao Lujun) and Department of Anesthesia (Yuan Yajing),Tianjin Medical University Cancer Institute& Hospital,Key Laboratory of Cancer Prevention and Therapy,National Clinical Research Center for Cancer,Tianjin 300060,China
Abstract： Radiation-induced heart disease (RIHD) is a common type of radiation-induced damages in chest radiotherapy. There are no obvious short-term symptoms in patients with RIHD. However, RIHD causes irreversible permanent damages to the heart over time, which undermines the quality of life. Patients with severe RIHD even have a risk of death from myocardial infarction caused by coronary atherosclerosis. This paper summarizes the research advances in epidemiology, diagnosis, mechanisms of radiation-induced injury in various parts of the heart, radiotherapy techniques, and treatment. Reduction in radiation range and dose, early diagnosis, and early treatment are recommended for patients to reduce heart injury and improve the quality of life.
Xu Liming,Chen Xi,Yuan Yajing et al. Research advances in radiation-induced heart disease[J]. Chinese Journal of Radiation Oncology, 2017, 26(3): 358-363.
[1] Darby SC,Ewertz M,McGale P,et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer[J].N Engl J Med,2013,368(11):987-998.DOI:10.1056/NEJMoa1209825. [2] Lee CKK,Aeppli D,Nierengarten ME.The need for long-term surveillance for patients treated with curative radiotherapy for Hodgkin’s disease:university of Minnesota experience[J].Int J Radiat Oncol Biol Phys,2000,48(1):169-179.DOI:10.1016/S0360-3016(00)00647-7. [3] Early Breast Cancer Trialists’Collaborative Group (EBCTCG).Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:an overview of the randomised trials[J].Lancet,2005,366(9503):2087-2106.DOI:10.1016/S0140-6736(05)67887-7. [4] Carver JR,Shapiro CL,Ng A,et al. American society of clinical oncology clinical evidence review on the ongoing care of adult cancer survivors:cardiac and pulmonary late effects[J].J Clin Oncol,2007,25(25):3991-4008.DOI:10.1200/JCO.2007.10.9777. [5] Hadaegh F,Ehteshami-Afshar S,Hajebrahimi MA,et al. Silent coronary artery disease and incidence of cardiovascular and mortality events at different levels of glucose regulation;results of greater than a decade follow-up[J].Int J Cardiol,2015,182:334-339.DOI:10.1016/j.ijcard.2015.01.017. [6] Prosnitz RG,Chen YH,Marks LB.Cardiac toxicity following thoracic radiation[J].Semin Oncol,2005,32(2 Suppl 3):S71-80.DOI:10.1053/j.seminoncol.2005.03.013. [7] Darby SC,McGale P,Taylor CW,et al. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer:prospective cohort study of about 300 000 women in US SEER cancer registries[J].Lancet Oncol,2005,6(8):557-565.DOI:10.1016/S1470-2045(05)70251-5. [8] Schellong G,Riepenhausen M,Bruch C,et al. Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for Hodgkin disease in children and adolescents:report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies[J].Pediatr Blood Cancer,2010,55(6):1145-1152.DOI:10.1002/pbc.22664. [9] Darby SC,Cutter DJ,Boerma M,et al. Radiation-related heart disease:current knowledge and future prospects[J].Int J Radiat Oncol Biol Phys,2010,76(3):656-665.DOI:10.1016/j.ijrobp.2009.09.064. [10] Hodgson DC.Late effects in the era of modern therapy for Hodgkin lymphoma[J].Hematology Am Soc Hematol Educ Program,2011,2011:323-329.DOI:10.1182/asheducation-2011.1.323. [11] Landau D,Adams EJ,Webb S,et al. Cardiac avoidance in breast radiotherapy:a comparison of simple shielding techniques with intensity-modulated radiotherapy[J].Radiother Oncol,2001,60(3):247-255.DOI:10.1016/S0167-8140(01)00374-7. [12] Gagliardi G,Constine LS,Moiseenko V,et al. Radiation dose-volume effects in the heart[J].Int J Radiat Oncol Biol Phys,2010,76(3 Suppl):S77-85.DOI:10.1016/j.ijrobp.2009.04.093. [13] Stewart FA.Mechanisms and dose-response relationships for radiation-induced cardiovascular disease[J].Ann ICRP,2012,41(3-4):72-79.DOI:10.1016/j.icrp.2012.06.031. [14] Lancellotti P,Nkomo VT,Badano LP,et al. Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults:a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography[J].J Am Soc Echocardiogr,2013,26(9):1013-1032.DOI:10.1016/j.echo.2013.07.005. [15] Dogan SM,Bilici HM,Bakkal H,et al. The effect of radiotherapy on cardiac function[J].Coron Artery Dis,2012,23(3):146-154.DOI:10.1097/MCA.0b013e32835115 d6. [16] Erven K,Jurcut R,Weltens C,et al. Acute radiation effects on cardiac function detected by strain rate imaging in breast cancer patients[J].Int J Radiat Oncol Biol Phys,2011,79(5):1444-1451.DOI:10.1016/j.ijrobp.2010.01.004. [17] Küpeli S,Hazirolan T,Varan A,et al. Evaluation of coronary artery disease by computed tomography angiography in patients treated for childhood Hodgkin′s lymphoma[J].J Clin Oncol,2010,28(6):1025-1030.DOI:10.1200/JCO.2009.25.2627. [18] Hatakenaka M,Yonezawa M,Nonoshita T,et al. Acute cardiac impairment associated with concurrent chemoradiotherapy for esophageal cancer:magnetic resonance evaluation[J].Int J Radiat Oncol Biol Phys,2012,83(1):e67-73.DOI:10.1016/j.ijrobp.2011.12.018. [19] Umezawa R,Ota H,Takanami K,et al. MRI findings of radiation-induced myocardial damage in patients with oesophageal cancer[J].Clin Radiol,2014,69(12):1273-1279.DOI:10.1016/j.crad.2014.08.010. [20] Machann W,Beer M,Breunig M,et al. Cardiac magnetic resonance imaging findings in 20-year survivors of mediastinal radiotherapy for Hodgkin′s disease[J].Int J Radiat Oncol Biol Phys,2011,79(4):1117-1123.DOI:10.1016/j.ijrobp.2009.12.054. [21] Zhang P,Hu XD,Yue JB,et al. Early detection of radiation-induced heart disease using 99mTc-MIBI SPECT gated myocardial perfusion imaging in patients with oesophageal cancer during radiotherapy[J].Radiother Oncol,2015,115(2):171-178.DOI:10.1016/j.radonc.2015.04.009. [22] Konski A,Li TY,Christensen M,et al. Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in 18F-FDG PET determination of myocardial activity after chemoradiotherapy for esophageal cancer[J].Radiother Oncol,2012,104(1):72-77.DOI:10.1016/j.radonc.2012.04.016. [23] Erven K,Florian A,Slagmolen P,et al. Subclinical cardiotoxicity detected by strain rate imaging up to 14 months after breast radiation therapy[J].Int J Radiat Oncol Biol Phys,2013,85(5):1172-1178.DOI:10.1016/j.ijrobp.2012.09.022. [24] D′Errico MP,Grimaldi L,Petruzzelli MF,et al. N-terminal pro-B-type natriuretic peptide plasma levels as a potential biomarker for cardiac damage after radiotherapy in patients with left-sided breast cancer[J].Int J Radiat Oncol Biol Phys,2012,82(2):e239-246.DOI:10.1016/j.ijrobp.2011.03.058. [25] Jaworski C,Mariani JA,Wheeler G,et al. Cardiac complications of thoracic irradiation[J].J Am Coll Cardiol,2013,61(23):2319-2328.DOI:10.1016/j.jacc.2013.01.090. [26] Hess SL,Jóhannsdóttir IM,Hamre H,et al. Adult survivors of childhood malignant lymphoma are not aware of their risk of late effects[J].Acta Oncol,2011,50(5):653-659.DOI:10.3109/0284186X.2010.550934. [27] Schultz-Hector S,Trott KR.Radiation-induced cardiovascular diseases:is the epidemiologic evidence compatible with the radiobiologic data?[J].Int J Radiat Oncol Biol Phys,2007,67(1):10-18.DOI:10.1016/j.ijrobp.2006.08.071. [28] Yarnold J,Brotons MCV.Pathogenetic mechanisms in radiation fibrosis[J].Radiother Oncol,2010,97(1):149-161.DOI:10.1016/j.radonc.2010.09.002. [29] Seemann I,Gabriels K,Visser NL,et al. Irradiation induced modest changes in murine cardiac function despite progressive structural damage to the myocardium and microvasculature[J].Radiother Oncol,2012,103(2):143-150.DOI:10.1016/j.radonc.2011.10.011. [30] Hansson GK.Inflammation,atherosclerosis,and coronary artery disease[J].N Engl J Med,2005,352(16):1685-1695.DOI:10.1056/NEJMra043430. [31] Stewart FA,Heeneman S,te Poele J,et al. Ionizing radiation accelerates the development of atherosclerotic lesions in ApoE-/-mice and predisposes to an inflammatory plaque phenotype prone to hemorrhage[J].Am J Pathol,2006,168(2):649-658.DOI:10.2353/ajpath.2006.050409. [32] Barjaktarovic Z,Shyla A,Azimzadeh O,et al. Ionising radiation induces persistent alterations in the cardiac mitochondrial function of C57BL/6 mice 40 weeks after local heart exposure[J].Radiother Oncol,2013,106(3):404-410.DOI:10.1016/j.radonc.2013.01.017. [33] Weintraub NL,Jones WK,Manka D.Understanding radiation-induced vascular disease[J].J Am Coll Cardiol,2010,55(12):1237-1239.DOI:10.1016/j.jacc.2009.11.053. [34] Sievert W,Trott KR,Azimzadeh O,et al. Late proliferating and inflammatory effects on murine microvascular heart and lung endothelial cells after irradiation[J].Radiother Oncol,2015,117(2):376-381.DOI:10.1016/j.radonc.2015.07.029. [35] Hayashi T,Morishita Y,Kubo Y,et al. Long-term effects of radiation dose on inflammatory markers in atomic bomb survivors[J].Am J Med,2005,118(1):83-86.DOI:10.1016/j.amjmed.2004.06.045. [36] Dunn MM,Drab EA,Rubin DB.Effects of irradiation on endothelial cell-polymorphonuclear leukocyte interactions[J].J Appl Physiol,1986,60(6):1932-1937. [37] Tribble DL,Barcellos-Hoff MH,Chu BM,et al. Ionizing radiation accelerates aortic lesion formation in fat-fed mice via SOD-inhibitable processes[J].Arterioscler Thromb Vasc Biol,1999,19(6):1387-1392.DOI:10.1161/01.ATV.19.6.1387. [38] Beckman JA,Thakore A,Kalinowski BH,et al. Radiation therapy impairs endothelium-dependent vasodilation in humans[J].J Am Coll Cardiol,2001,37(3):761-765.DOI:10.1016/S0735-1097(00)01190-6. [39] Sugihara T,Hattori Y,Yamamoto Y,et al. Preferential impairment of nitric oxide-mediated endothelium-dependent relaxation in human cervical arteries after irradiation[J].Circulation,1999,100(6):635-641.DOI:10.1161/01.CIR.100.6.635. [40] Basavaraju SR,Easterly CE.Pathophysiological effects of radiation on atherosclerosis development and progression,and the incidence of cardiovascular complications[J].Med Phys,2002,29(10):2391-2403.DOI:10.1118/1.1509442. [41] Little MP,Gola A,Tzoulaki I.A model of cardiovascular disease giving a plausible mechanism for the effect of fractionated low-dose ionizing radiation exposure[J].PLoS Comput Biol,2009,5(10):e1000539.DOI:10.1371/journal.pcbi.1000539. [42] Adams MJ,Hardenbergh PH,Constine LS,et al. Radiation-associated cardiovascular disease[J].Crit Rev Oncol Hematol,2003,45(1):55-75.DOI:10.1016/S1040-8428(01)00227-X. [43] Stewart FA,Hoving S,Russell NS.Vascular damage as an underlying mechanism of cardiac and cerebral toxicity in irradiated cancer patients[J].Radiat Res,2010,174(6b):865-869.DOI:10.1667/RR1862.1. [44] Schultz-Hector S.Radiation-induced heart disease:review of experimental data on dose reponse and pathogenesis[J].Int J Radiat Biol,1992,61(2):149-160.DOI:10.1080/09553009214550761. [45] Marks LB,Yu XL,Prosnitz RG,et al. The incidence and functional consequences of RT-associated cardiac perfusion defects[J].Int J Radiat Oncol Biol Phys,2005,63(1):214-223.DOI:10.1016/j.ijrobp.2005.01.029. [46] Monceau V,Llach A,Azria D,et al. Epac contributes to cardiac hypertrophy and amyloidosis induced by radiotherapy but not fibrosis[J].Radiother Oncol,2014,111(1):63-71.DOI:10.1016/j.radonc.2014.01.025. [47] Gabriels K,Hoving S,Seemann I,et al. Local heart irradiation of ApoE-/-mice induces microvascular and endocardial damage and accelerates coronary atherosclerosis[J].Radiother Oncol,2012,105(3):358-364.DOI:10.1016/j.radonc.2012.08.002. [48] Boerma M,Wang JR,Wondergem J,et al. Influence of mast cells on structural and functional manifestations of radiation-induced heart disease[J].Cancer Res,2005,65(8):3100-3107.DOI:10.1158/0008-5472. [49] Evans RA,Tian YC,Steadman R,et al. TGF-β1-mediated fibroblast-myofibroblast terminal differentiation—the role of smad proteins[J].Exp Cell Res,2003,282(2):90-100.DOI:10.1016/S0014-4827(02)00015-0. [50] Nadlonek NA,Weyant MJ,Yu JA,et al. Radiation induces osteogenesis in human aortic valve interstitial cells[J].J Thorac Cardiovasc Surg,2012,144(6):1466-1470.DOI:10.1016/j.jtcvs.2012.08.041. [51] Heidenreich PA,Schnittger I,Strauss HW,et al. Screening for coronary artery disease after mediastinal irradiation for Hodgkin′s disease[J].J Clin Oncol,2007,25(1):43-49.DOI:10.1200/JCO.2006.07.0805. [52] Russell NS,Lara PC,Grummels A,et al. In vitro differentiation characteristics of human skin fibroblasts:correlations with radiotherapy-induced breast fibrosis in patients[J].Int J Radiat Biol,2000,76(2):231-240.DOI:10.1080/095530000138880. [53] Krüse JJCM,Zurcher C,Strootman EG,et al. Structural changes in the auricles of the rat heart after local ionizing irradiation[J].Radiother Oncol,2001,58(3):303-311.DOI:10.1016/S0167-8140(00)00327-3. [54] Hoving S,Heeneman S,Gijbels MJJ,et al. Single-dose and fractionated irradiation promote initiation and progression of atherosclerosis and induce an inflammatory plaque phenotype in ApoE-/-mice[J].Int J Radiat Oncol Biol Phys,2008,71(3):848-857.DOI:10.1016/j.ijrobp.2008.02.031. [55] Hoving S,Heeneman S,Gijbels MJJ,et al. NO-donating aspirin and aspirin partially inhibit age-related atherosclerosis but not radiation-induced atherosclerosis in ApoE null mice[J].PLoS One,2010,5(9):e12874.DOI:10.1371/journal.pone.0012874. [56] Trochu JN,Mital S,Zhang XP,et al. Preservation of NO production by statins in the treatment of heart failure[J].Cardiovasc Res,2003,60(2):250-258.DOI:10.1016/j.cardiores.2003.08.003. [57] Haydont V,Mathé D,Bourgier C,et al. Induction of CTGF by TGF-β1 in normal and radiation enteritis human smooth muscle cells:smad/rho balance and therapeutic perspectives[J].Radiother Oncol,2005,76(2):219-225.DOI:10.1016/j.radonc.2005.06.029. [58] Monceau V,Pasinetti N,Schupp C,et al. Modulation of the Rho/ROCK pathway in heart and lung after thorax irradiation reveals targets to improve normal tissue toxicity[J].Curr Drug Targets,2010,11(11):1395-1404.DOI:10.2174/1389450111009011395. [59] Liu H,Xiong M,Xia YF,et al. Studies on pentoxifylline and tocopherol combination for radiation-induced heart disease in rats[J].Int J Radiat Oncol Biol Phys,2009,73(5):1552-1559.DOI:10.1016/j.ijrobp.2008.12.005. [60] Yarom R,Harper IS,Wynchank S,et al. Effect of captopril on changes in rats′ hearts induced by long-term irradiation[J].Radiat Res,1993,133(2):187-197.DOI:10.2307/3578356. [61] Cardinale D,Colombo A,Sandri MT,et al. Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition[J].Circulation,2006,114(23):2474-2781.DOI:10.1161/CIRCULATIONAHA.106.635144. [62] Leborgne L,Pakala R,Dilcher C,et al. Effect of antioxidants on atherosclerotic plaque formation in balloon-denuded and irradiated hypercholesterolemic rabbits[J].J Cardiovasc Pharmacol,2005,46(4):540-547.DOI:10.1097/01.fjc.0000179436.03502.26. [63] Belvisi MG,Mitchell JA.Targeting PPAR receptors in the airway for the treatment of inflammatory lung disease[J].Br J Pharmacol,2009,158(4):994-1003.DOI:10.1111/j.1476-5381.2009.00373.x. [64] Gürses I,zeren M,Serin M,et al. Histopathological evaluation of melatonin as a protective agent in heart injury induced by radiation in a rat model[J].Pathol Res Pract,2014,210(12):863-871.DOI:10.1016/j.prp.2014.08.006. [65] Yuen DA,Connelly KA,Advani A,et al. Culture-modified bone marrow cells attenuate cardiac and renal injury in a chronic kidney disease rat model via a novel antifibrotic mechanism[J].PLoS One,2010,5(3):e9543.DOI:10.1371/journal.pone.0009543. [66] Chang ASY,Smedira NG,Chang CL,et al. Cardiac surgery after mediastinal radiation:extent of exposure influences outcome[J].J Thorac Cardiovasc Surg,2007,133(2):404-413.e3.DOI:10.1016/j.jtcvs.2006.09.041. [67] Handa N,McGregor CGA,Daly RC,et al. Heart transplantation for radiation-associated end-stage heart failure[J].Transpl Int,2000,13(2):162-165.DOI:10.1111/j.1432-2277.2000.tb01058.x. [68] DePasquale EC,Nasir K,Jacoby DL.Outcomes of adults with restrictive cardiomyopathy after heart transplantation[J].J Heart Lung Transplant,2012,31(12):1269-1275.DOI:10.1016/j.healun.2012.09.018.
2017, Vol. 26 
